We are live on ! Find out more
BCPEMI

Bain Capital Public Equity Management II Portfolio holdings

AUM $62.1M
1-Year Est. Return 25.46%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+25.46%
3 Year Est. Return
+200.73%
5 Year Est. Return
+313.45%
10 Year Est. Return
–
AUM
$2.86B
AUM Growth
+$524M
Cap. Flow
+$442M
Cap. Flow %
15.46%
Top 10 Hldgs %
46.51%
Holding
66
New
15
Increased
20
Reduced
13
Closed
12

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$136M
2
AMP icon
Ameriprise Financial
AMP
+$136M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$69.8M
4
OWL icon
Blue Owl Capital
OWL
+$54.8M
5
FOUR icon
Shift4
FOUR
+$54.2M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$110M
2
EQH icon
Equitable Holdings
EQH
+$104M
3
STZ icon
Constellation Brands
STZ
+$91M
4
STNE icon
StoneCo
STNE
+$88.7M
5
FIVN icon
FIVE9
FIVN
+$71.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.28%
2 Technology 23.1%
3 Financials 18.65%
4 Healthcare 9.43%
5 Communication Services 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EEM icon
26
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.9B
$35.6M 1.24%
+706,000
New +$36.8M
DNA icon
27
Ginkgo Bioworks
DNA
$506M
$35.2M 1.23%
+75,975
New +$37M
SNY icon
28
Sanofi
SNY
$104B
$27.6M 0.97%
573,044
-36,944
-6% -$1.88M
EWBC icon
29
East-West Bancorp
EWBC
$18.2B
$27M 0.94%
+348,020
New +$25.3M
XBI icon
30
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$24.2M 0.85%
192,500
+187,675
+3,890% +$24.2M
IMCR icon
31
Immunocore
IMCR
$1.74B
$23.7M 0.83%
638,205
+163,651
+34% +$5.52M
CYTK icon
32
Cytokinetics
CYTK
$10.6B
$23.3M 0.81%
651,613
+384,347
+144% +$11.3M
BAC icon
33
PUT
Bank of America
BAC
$448B
$22.6M 0.79%
+533,400
New +$21.5M
BCRX icon
34
BioCryst Pharmaceuticals
BCRX
$2.64B
$21.2M 0.74%
1,472,471
-88,259
-6% -$1.39M
UBER icon
35
Uber
UBER
$160B
$20.2M 0.7%
450,212
– –
RCUS icon
36
Arcus Biosciences
RCUS
$3.66B
$15.9M 0.55%
+454,863
New +$14.2M
CCK icon
37
CALL
Crown Holdings
CCK
$13.1B
$14.4M 0.5%
+142,500
New +$15M
FISV
38
CALL
Fiserv Inc
FISV
$28B
$13.6M 0.48%
+125,600
New +$14M
HCAQ
39
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$13.4M 0.47%
1,350,000
– –
FXI icon
40
PUT
iShares China Large-Cap ETF
FXI
$4.25B
$11.3M 0.4%
290,600
+279,100
+2,427% +$11.5M
HZNP
41
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$11M 0.38%
+100,000
New +$10.4M
IQV icon
42
IQVIA
IQV
$40.1B
$9.1M 0.32%
37,973
-1
-0% -$252
AFMD
43
DELISTED
Affimed
AFMD
$7.09M 0.25%
114,801
-8,940
-7% -$588K
ANAC
44
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$5.84M 0.2%
599,517
– –
OMER icon
45
Omeros
OMER
$984M
$5.52M 0.19%
400,072
-25,693
-6% -$385K
XMTR icon
46
Xometry
XMTR
$5.24B
$5.1M 0.18%
+88,431
New +$6.13M
CRIS icon
47
Curis
CRIS
$4.83M
$3.42M 0.12%
1,094
-74
-6% -$231K
BCRX icon
48
CALL
BioCryst Pharmaceuticals
BCRX
$2.64B
$2.87M 0.1%
200,000
+197,500
+7,900% +$3.11M
ENDP
49
PUT
DELISTED
Endo International plc
ENDP
$2.69M 0.09%
830,000
+824,000
+13,733% +$2.91M
CCCS.WS
50
DELISTED
CCC Intelligent Solutions Holdings Inc. Redeemable warrants, each whole warrant exercisable for one
CCCS.WS
$898K 0.03%
+387,000
New +$936K
1
2
3

Similar funds

RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
KWM
KW Wealth Management Sacramento, California $65.9M AUM
AC
AIFG Consultants Halfmoon, New York $58.2M AUM 20.27% 1-Year Est. Return
RWA
Redmont Wealth Advisors Chicago, Illinois $66M AUM 13.09% 1-Year Est. Return
VI
VanderPol Investments Caledonia, Michigan $57.5M AUM 14.56% 1-Year Est. Return
QEI
QSV Equity Investors Naperville, Illinois $67.6M AUM 0.29% 1-Year Est. Return
BBW
Blue Barn Wealth Orem, Utah $68.7M AUM 16.42% 1-Year Est. Return

Bain Capital Public Equity Management II's Q3 2021 Portfolio in Review

As of Q3 2021, Bain Capital Public Equity Management II held 66 positions worth $2.86B, up 22% from $2.34B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Bain Capital Public Equity Management II deployed $442M of net new capital in Q3 2021, opening 15 new positions and adding to 20 existing holdings. Its largest new stake was Salesforce: 536,786 shares worth $146M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was ServiceNow, an estimated $63.8M trimmed.

  • Bain Capital Public Equity Management II's largest Q3 2021 buy was Salesforce: 536,786 shares worth $146M.
  • Bain Capital Public Equity Management II added most to Shift4 in Q3 2021, an estimated $54.2M increase.
  • Bain Capital Public Equity Management II's biggest Q3 2021 reduction was ServiceNow, cutting an estimated $63.8M.
  • Bain Capital Public Equity Management II fully exited Charles Schwab in Q3 2021, selling an estimated $110M.
  • Bain Capital Public Equity Management II's ten largest holdings make up 47% of its $2.86B portfolio in Q3 2021.
  • Bain Capital Public Equity Management II opened 15 new positions and closed 12 in Q3 2021.
  • Bain Capital Public Equity Management II's portfolio value rose 22% quarter-over-quarter to $2.86B.

Based on Bain Capital Public Equity Management II's 13F filing for Q3 2021, filed 15 Nov 2021.